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Conclusions: Several previous studies reported that formation of new
blood vessels in the subchondral bone was related with degeneration of
articular cartilage. In this study, no signiﬁcant differences were elucidated
in the angiogenesis of subchondral bone using supernatant from explants
culture, despite the fact that signiﬁcant differences was found in histolog-
ical examination. The angiogenesis of subchondral bone may be a slowly
progressive process, as well as the progression of knee OA, and it is possible
that the peak of this process was not detected in this study.
Animal models
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Purpose: Prominent proteins released by activated macrophages are the
“alarmins” S100 A8 and A9. Both proteins accumulate in inﬂammatory
synovial ﬂuids (up to 50 μg/ml) and have been postulated to be involved
in the pathogenesis of rheumatic diseases like RA. S100A8 is assumed
to be the active component whereas S100A9 functions as the regulatory
subunit preventing S100A8 from degradation. The aim is to study the active
involvement of S100A8/A9 in cartilage destruction in two murine models
of osteoarthritis.
Methods: Experimental OA was either induced by injection of collagenase
into murine knee joints, which causes local instability or by transsection of
the medial anterior meniscotibial ligament which leads to destabilisation
of the medial meniscus (DMM). OA phenotypes were studied within 8
weeks after induction. Collagenase-induced-osteoarthritis involves chronic
synovial activation in contrast to DMM. Synovial expression of mRNA and
protein levels of S100A8 and S100A9 during the course of osteoarthritis was
performed by using RT-PCR and immunolocalisation. Both models were
induced in S100A9 deﬁcient mice (myeloid cells also lack S100A8 at the
protein level). Synovial activation and cartilage destruction was measured
by histology. Cartilage pathology was scored in a blinded way using an ar-
bitrary score that considered both grade (0-6) and stage (0-5) of pathology.
Primary murine chondrocytes were stimulated with rS100A8,rS100A9 and
S100A8/S100A9 complex.
Results: Kinetic studies show that mRNA levels of S100A8 and S100A9
were strongly elevated in synovium during the course of collagenase-
induced osteoarthritis (at day 7 between 20-35 fold and day 21 between
30-65 fold). In contrast, cytokine expression like IL-1 was already low at
day 7. Expression of S100A8 and S100A9 protein nicely correlated with
thickening of the synovial lining layer and were localized particularly in
activated macrophages. In contrast, in the mechanically induced DMM
model, marginal expression of both proteins was seen, only evident at
day 7 after induction and consistent with limited synovial thickening. Of
interest, particularly the active form of S100A8 was expressed in chon-
drocytes of cartilage areas in which lesions preferentially developed at
later time-points. When collagenase-induced-osteoarthritis was elicited in
S100A9-/- mice, signiﬁcantly lower synovial activation was observed when
compared to WT mice. Synovial activation was 62% lower at day 42. In
addition, cartilage destruction was measured in various cartilage surfaces
(medial and lateral tibia and femur) of the knee joint. Cartilage destruction
was strongly and signiﬁcantly lower in all surfaces and ranged from a
45% reduction in the lateral tibia to 73% reduction in the medial femur.
In vitro, S100A8 stimulated primary chondrocytes to upregulate MMPs
particularly MMP-3 (64 fold increase). S100A9 and S100A8/A9 complex
were less effective. In contrast, in the DMM model, where S100A8 was
hardly expressed in the synovium, no differences in cartilage destruction
were observed in S100A9-/- and WT mice.
Conclusions: Alarmins S100A8/A9 play a crucial role in cartilage destruc-
tion in an osteoarthritis model that shows clear synovial involvement.
S100A8/A9 expression in the synovium causes pathology probably by
stimulating MMP-mediated damage in the cartilage matrix.
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Purpose: No cures currently exist for the degenerative joint disease os-
teoarthritis (OA). Furthermore, the complex and multi-variable nature of
OA continues to challenge the development of effective therapies. In an
attempt to identify potential targets for disease modifying osteoarthritis
drugs (DMOADs), our lab recently established a surgical model of OA to
study gene expression changes in degenerating cartilage. Transforming
growth factor alpha (TGFα) gene expression was upregulated in our model
and further in vitro studies showed that TGFα suppressed chondrocyte
expression of anabolic factors aggrecan and type II collagen and increased
expression of the catabolic factor matrix metalloproteinase 13 (MMP13).
We thus identiﬁed TGFα as a novel therapeutic OA target. The purpose of
this project is to examine the role of TGFα and its receptor, the epidermal
growth factor receptor (EGFR), in the development of OA in vivo. We
hypothesize that inhibition of TGFα signaling will delay disease progression
in surgical OA models.
Methods: Adult male Sprague Dawley rats underwent anterior cruciate
ligament transection and partial medial menisectomy (OA surgery) or sham
surgery. All animals were subjected to forced mobilization of their joints
three times a week. Furthermore, animals received local administration
of either the EGFR inhibitor AG1478 or vehicle via mini drug pumps. At
0, 4, 7 and 10 weeks post-surgery, animals were sacriﬁced, knee joint
histopathology was scored and blood samples were collected to analyze
biomarkers for type II collagen breakdown and synthesis. In addition, adult
male Tgfa null mice and control littermates received either meniscotibial
transection (MTX) or sham surgery. At 7 weeks post-surgery knee joint
histopathology was scored and tissues were immunostained for disease
markers. Since some features of cartilage and bone development are known
to be recapitulated during the disease process, skeletal development in Tgfa
null mice was also examined.
Results: Rats that received OA surgery plus AG1478 had signiﬁcantly lower
OARSI scores than those that received OA surgery plus vehicle at 4 and 7
weeks. Biomarker analysis showed that EGFR inhibition results in greater
type II collagen synthesis and decreases collagen degradation during early
time points. MTX surgery produced mild OA in mice after 7 weeks.
Tgfa null mice had lower OARSI scores and expressed less MMP13 and
type II collagen neoepitopes than their control littermates. Tgfa null mice
also showed transient growth retardation after birth. Histological analyses
demonstrated a wider hypertrophic zone of the growth plate. TRAP staining
showed a decrease in osteoclasts at the cartilage-bone interface, suggesting
that removal of hypertrophic cartilage is delayed. These phenotypes are
absent in adult mice.
Conclusions: TGFα signaling plays an important role in osteoarthritis pro-
gression in vivo and should be investigated further as a potential target for
DMOAD development.
